List of Excipients in API hydrochlorothiazide and triamterene
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing hydrochlorothiazide and triamterene
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
GlaxoSmithKline LLC | DYAZIDE | hydrochlorothiazide and triamterene | 0007-3650 | BENZYL ALCOHOL | |
GlaxoSmithKline LLC | DYAZIDE | hydrochlorothiazide and triamterene | 0007-3650 | CELLULOSE, MICROCRYSTALLINE | |
GlaxoSmithKline LLC | DYAZIDE | hydrochlorothiazide and triamterene | 0007-3650 | CETYLPYRIDINIUM CHLORIDE | |
GlaxoSmithKline LLC | DYAZIDE | hydrochlorothiazide and triamterene | 0007-3650 | D&C RED NO. 33 | |
GlaxoSmithKline LLC | DYAZIDE | hydrochlorothiazide and triamterene | 0007-3650 | FD&C YELLOW NO. 6 | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing hydrochlorothiazide and triamterene
Detailed excipient profiles for hydrochlorothiazide and triamterene
Excipient focus: BENZYL ALCOHOL
hydrochlorothiazide and triamterene drug variants containing BENZYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing BENZYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
hydrochlorothiazide and triamterene drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CETYLPYRIDINIUM CHLORIDE
hydrochlorothiazide and triamterene drug variants containing CETYLPYRIDINIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing CETYLPYRIDINIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
hydrochlorothiazide and triamterene drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 33
hydrochlorothiazide and triamterene drug variants containing D&C RED NO. 33
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing D&C RED NO. 33
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
hydrochlorothiazide and triamterene drug variants containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
hydrochlorothiazide and triamterene drug variants containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
hydrochlorothiazide and triamterene drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
hydrochlorothiazide and triamterene drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
hydrochlorothiazide and triamterene drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
hydrochlorothiazide and triamterene drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
hydrochlorothiazide and triamterene drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
hydrochlorothiazide and triamterene drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLYCINE
hydrochlorothiazide and triamterene drug variants containing GLYCINE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing GLYCINE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
hydrochlorothiazide and triamterene drug variants containing LACTOSE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing LACTOSE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
hydrochlorothiazide and triamterene drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
hydrochlorothiazide and triamterene drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
hydrochlorothiazide and triamterene drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
hydrochlorothiazide and triamterene drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
hydrochlorothiazide and triamterene drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
hydrochlorothiazide and triamterene drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
hydrochlorothiazide and triamterene drug variants containing SODIUM BICARBONATE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing SODIUM BICARBONATE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
hydrochlorothiazide and triamterene drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
hydrochlorothiazide and triamterene drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
hydrochlorothiazide and triamterene drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
>Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.